Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nalmefene Hydrochloride Hydrate Tablets 10mg Specified Drug-use Results Survey (the Safety and the Prognosis After Achieving Reduced Alcohol Intake)

NCT04107051 is registered in ClinicalTrials.gov with Otsuka Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT04107051
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04107051 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nalmefene Hydrochloride Hydrate Tablets 10mg Specified Drug-use Results Survey (the Safety and the Prognosis After Achieving Reduced Alcohol Intake)
Lead sponsor
Otsuka Pharmaceutical Co., Ltd.
Phase
Observational
Overall status
Completed
Start date
October 1, 2019
Completion date
February 6, 2024
Enrollment
533 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol dependence